Aridis Pharmaceuticals, Inc. Gains 15.52%
Thu, Jan 27, 2022 at 05:30 PM
Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ) soared at $2.01, a gain of 15.5%. On Wed, Jan 26, 2022, ARDS:NASDAQ touched a New 2-Week Intraday High of $2.15. The stock appeared on our News Catalysts scanner on Wed, Dec 29, 2021 at 02:05 PM in the 'MISCELLANEOUS' category. From Thu, Jan 13, 2022, the stock recorded 50.00% Up Days and 55.56% Green Days
The stock spiked on Mon, Jan 24, 2022 at $2.36 with a volume of 11M+.
About Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ)
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
Top 10 Gainers:
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 110.36%
- The National Security Group, Inc. (NSEC:NASDAQ), 71.1%
- Sidus Space Inc. (SIDU:NASDAQ), 31.55%
- Galapagos NV (GLPG:NASDAQ), 22.47%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 20.68%
- LSI Industries Inc. (LYTS:NASDAQ), 17.83%
- Save Foods Inc. (SVFD:NASDAQ), 17.68%
- TSR, Inc. (TSRI:NASDAQ), 15.59%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 15.52%
- PyroGenesis (PYR:NASDAQ), 14.39%